[ET Net News Agency, 20 August 2021] CSPC PHARMA (01093) fell 4.95% to HK$10.36,
dipping below the 100-D SMA of HK$10.611.
It hits an intra-day low of HK$10.28, and an intra-day high of HK$11.24. The total
shares traded was 20.29 million, with a value of HK$214.62m. The active buy/sell ratio is
40:60, with net selling turnover of HK$39.35m. MORGAN STANLEY HK SEC accounts for greatest
net responsive buying turnover of HK$9.02m, with volume weighted average price of
HK$10.582. CLSA LTD accounts for greatest net responsive selling turnover of HK$11.9m,
with volume weighted average price of HK$10.608. The stock has fallen a combined 7.83%
over the past 3 consecutive trading days.
The Hang Seng Index now fell 330 points, or 1.31% to 24,985; the Hang Seng China
Enterprises Index now fell 124 points, or 1.4% to 8,791; the Hang Seng TECH Index now fell
93 points, or 1.55% to 5,950; with an overall turnover of HK$65.09b.
The SSE Composite Index now fell 36 points, or 1.04% to 3,429, with an overall turnover
of RMB247.87b.
The SZSE Component Index now fell 171 points, or 1.19% to 14,315, with an overall
turnover of RMB157.91b.
Basic Information
-------------------------------------------
Nominal 10.360 % Chg -4.95%
High 11.240 Low 10.280
Shares Tr 20.29m Turnover 214.62m
10-D SMA 10.938 %H.V 42.998
20-D SMA 10.680 VWAP 10.577
50-D SMA 10.941 RSI14 41.538
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 40:60, with net selling
turnover of HK$39.35m, falling a combined 7.83% over the past 3 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
CSPC PHARMA (01093) 10.36 -4.95
SIHUAN PHARM (00460) 2.16 -4.00
CMS (00867) 16.58 -3.83
SINO BIOPHARM (01177) 6.44 -2.72
3SBIO (01530) 6.91 -5.86
LUYE PHARMA (02186) 3.80 -2.56
FOSUN PHARMA (02196) 50.50 -5.52
WUXI APPTEC (02359) 136.90 -5.65
HANSOH PHARMA (03692) 25.40 -1.55
PHARMARON (03759) 150.10 -4.27
-------------------------------------------------
(ed)